welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Catabasis Quarterly: Updates on edasalonexent and clinical trials

Happy New Year! As 2019 kicks off, our Phase 3 PolarisDMD clinical trial of edasalonexent in Duchenne muscular dystrophy (DMD) continues to gain momentum. We are excited to share that a total of 10 clinical trial sites have officially launched in the U.S., with our international sites coming soon. We are enrolling boys ages 4 to 7 (up to 8th birthday), any mutation type, who have not been on steroids for at least 6 months. Stay up to date with the latest site initiations by following us on social media (@CatabasisPharma on Facebook, Twitter, and Instagram). 

Catabasis Quarterly: Updates On Edasalonexent And Clinical Trials